2024-04-04 Purchase(A) | 2024-04-17 4:14 pm | Surrozen Inc. | SRZN | COLUMN GROUP III GP LP COLUMN GROUP III-A LP COLUMN GROUP III LP 10% Owner | 193,548 | $15.5 | $2,999,994 | 326,992 (Indirect) | View |
2024-04-04 Purchase | 2024-04-08 4:23 pm | Surrozen Inc. | SRZN | COLUMN GROUP III GP LP COLUMN GROUP III-A LP COLUMN GROUP III LP 10% Owner | 193,548 | $15.5 | $2,999,994 | 2,236,955 (Indirect) | View |
2024-02-12 Purchase | 2024-02-14 4:15 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 2,222,222 | $4.5 | $9,999,999 | 22,999,565 (Indirect) | View |
2023-11-15 Purchase | 2023-11-17 4:30 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 22,631 | $0.6852 | $15,507 | 21,743,413 (Indirect Direct) | View |
2023-03-10 Purchase | 2023-03-14 4:12 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 6,779 | $2.5956 | $17,596 | 20,777,343 (Indirect) | View |
2023-02-08 Purchase | 2023-02-10 4:32 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 1,500,000 | $2.6 | $3,900,000 | 20,770,564 (Indirect) | View |
2023-01-30 Purchase | 2023-02-01 4:50 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 184,272 | $4.9986 | $921,110 | 21,720,782 (Indirect Direct) | View |
2023-01-23 Purchase | 2023-01-25 4:35 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 9,900 | $4.9994 | $49,494 | 21,536,510 (Indirect Direct) | View |
2023-01-19 Purchase | 2023-01-23 4:25 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 69,739 | $2.4979 | $174,201 | 19,270,564 (Indirect) | View |
2023-01-19 Purchase | 2023-01-23 4:22 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 38,139 | $4.9976 | $190,603 | 21,526,610 (Indirect Direct) | View |
2023-01-17 Purchase | 2023-01-19 4:18 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 185,151 | $2.5105 | $464,827 | 19,200,825 (Indirect) | View |
2023-01-12 Purchase | 2023-01-17 4:34 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 5,378 | $4.9466 | $26,603 | 21,488,471 (Indirect Direct) | View |
2023-01-10 Purchase | 2023-01-12 4:37 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 309,070 | $4.7865 | $1,479,359 | 21,483,093 (Indirect Direct) | View |
2022-12-12 Purchase | 2022-12-14 4:29 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 300 | $4.9767 | $1,493 | 21,174,023 (Indirect Direct) | View |
2022-11-21 Purchase | 2022-11-23 4:17 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 40,327 | $4.9988 | $201,588 | 21,173,723 (Indirect Direct) | View |
2022-11-21 Purchase | 2022-11-23 4:12 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 9,615,384 | $2.6 | $24,999,998 | 19,015,674 (Indirect) | View |
2022-11-03 Purchase | 2022-11-07 4:20 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 139,148 | $4.9187 | $684,427 | 21,133,396 (Indirect Direct) | View |
2022-10-27 Purchase | 2022-10-31 5:19 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 76,877 | $4.8602 | $373,638 | 20,994,248 (Indirect Direct) | View |
2022-10-25 Purchase | 2022-10-27 6:55 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 123,820 | $4.8088 | $595,428 | 20,917,371 (Indirect Direct) | View |
2022-06-09 Purchase | 2022-06-13 5:05 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 984,161 | $13.5 | $13,286,174 | 18,143,374 (Indirect Direct) | View |
2022-06-02 Purchase | 2022-06-06 4:44 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 34,200 | $13.03 | $445,739 | 18,110,897 (Indirect Direct) | View |
2022-05-31 Purchase | 2022-06-02 4:28 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 153,806 | $13.46 | $2,069,667 | 18,109,768 (Indirect Direct) | View |
2022-05-26 Purchase | 2022-05-31 5:02 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 22,911 | $13.49 | $309,035 | 18,104,692 (Indirect Direct) | View |
2022-05-24 Purchase | 2022-05-26 4:13 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 61,120 | $13.42 | $819,948 | 18,103,936 (Indirect Direct) | View |
2022-05-19 Purchase | 2022-05-23 4:14 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 39,700 | $13.36 | $530,454 | 18,101,919 (Indirect Direct) | View |
2022-05-17 Purchase | 2022-05-19 4:39 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 151,699 | $13.33 | $2,022,004 | 18,100,609 (Indirect Direct) | View |
2022-05-13 Purchase | 2022-05-17 4:22 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 162,531 | $2.6327 | $427,891 | 18,095,603 (Indirect Direct) | View |
2022-05-11 Purchase | 2022-05-13 5:32 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 166,350 | $11.43 | $1,902,032 | 18,090,240 (Indirect Direct) | View |
2022-05-09 Purchase | 2022-05-11 6:14 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 114,440 | $10.95 | $1,252,982 | 18,084,750 (Indirect Direct) | View |
2022-01-24 Purchase | 2022-01-26 7:14 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 849,701 | $0 | $0 | 18,080,973 (Indirect Direct) | View |
2021-02-17 Sale | 2021-02-19 5:31 pm | CONSTELLATION PHARMACEUTICALS INC | CNST | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP COLUMN GROUP GP LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim 10% Owner | 10,000 | $36.95 | $369,503 | 6,230,638 (Indirect Direct) | View |
2020-11-16 Sale | 2020-11-18 7:06 pm | Revolution Medicines Inc. | RVMD | COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP PONOI CAPITAL LP Ponoi Capital II LP Ponoi Management LLC Ponoi II Management LLC Kutzkey Tim GOEDDEL DAVID V 10% Owner | 2,027,156 | $36.4 | $73,788,478 | 5,950,228 (Indirect Direct) | View |
2020-09-01 Purchase | 2020-09-03 5:32 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Svennilson Peter GOEDDEL DAVID V Director 10% Owner | 64,089 | $17.65 | $1,131,358 | 18,242,932 (Indirect Direct) | View |
2020-08-27 Purchase | 2020-08-31 5:02 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner | 62,494 | $17.83 | $1,114,382 | 18,178,843 (Indirect Direct) | View |
2020-08-21 Purchase | 2020-08-25 6:50 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner | 18,445 | $17.96 | $331,349 | 18,116,349 (Indirect Direct) | View |